Lisocabtagene Maraleucel (liso-cel) As Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplantation (HSCT): Final Analysis of the Phase 2 PILOT Study

This article has no abstract
Epistemonikos ID: d8c4d5748b7287946331a7e7204a234089b6eddb
First added on: Feb 17, 2025